NemaLife
NemaLife is a TechBio company revolutionizing ingredient discovery and development by using proprietary AI-enabled microfluidic organism-on-chip technology. Their platform accelerates product development timelines by 10x and reduces costs by 10x compared to traditional mammalian testing, while significantly reducing reliance on animal testing and conserving environmental resources. NemaLife partners with companies in food, nutraceutical, probiotics, and pharmaceutical industries to deliver safe, healthy, and sustainable products. Their technology has validated many ingredient classes, with several products entering clinical trials, positioning them as a leader in sustainable, high-throughput preclinical discovery.
NemaLife
NemaLife is a TechBio company revolutionizing ingredient discovery and development by using proprietary AI-enabled microfluidic organism-on-chip technology. Their platform accelerates product development timelines by 10x and reduces costs by 10x compared to traditional mammalian testing, while significantly reducing reliance on animal testing and conserving environmental resources. NemaLife partners with companies in food, nutraceutical, probiotics, and pharmaceutical industries to deliver safe, healthy, and sustainable products. Their technology has validated many ingredient classes, with several products entering clinical trials, positioning them as a leader in sustainable, high-throughput preclinical discovery.
TL;DR
Founded: 2018
Headquarters: Lubbock, Texas
Technology: AI-enabled microfluidics organism-on-chip using C. elegans
Applications: Ingredient discovery for food, nutraceuticals, supplements, and related industries
Employees (reported): 32
Company Overview
Problem Domain
High-cost, slow, and resource-intensive preclinical testing for ingredient validation and product development.
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Latest recorded funding event was a grant; reported lead federal research funder.
Strategic investment and technology partnership announced.
Investor Signal
“Mix of strategic corporate investment and U.S. federal research grant funding (including Motif FoodWorks and federal institutes)”